唾液蛋白质组和蛋白质组用于改善慢性阻塞性肺病知识
Fei Long1, Xiaoyin Zeng2, Fengyan Wang3
1Sino-French Hoffmann Institute, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Journal of proteomics
|January 21, 2026
概括
这项研究表明,原始诱导是COPD等呼吸道疾病中液体活检的宝贵来源. 过辅助样本制备方法改善了用于综合性疾病分析的蛋白质识别.
科学领域:
- 蛋白质组学和光蛋白质组学
- 呼吸系统疾病研究研究
- 发现生物标志物的发现.
背景情况:
- 诱导唾液分析为呼吸系统疾病提供了洞察力.
- 蛋白质和蛋白质的方法对于了解疾病病理学至关重要.
- 目前用于唾液分析的方法需要优化,以便进行全面的分子分析.
研究的目的:
- 评估原始诱导作为慢性阻塞性肺病 (COPD) 液体活检的来源.
- 建立和评估样蛋白质和蛋白质分析方法.
- 为了创建COPD唾液蛋白质和蛋白质的初步地图.
主要方法:
- 收集了COPD患者的诱导唾液样本.
- 使用三个酶性消化方法进行蛋白质和蛋白质分析:凝,溶液和过器辅助样本制备 (FASP).
- 对比了不同消化方法的有效性,用于蛋白质和蛋白质的识别.
主要成果:
- 与加工样本相比,原始唾液样本产生了更多的鉴定蛋白和蛋白.
- 通过FASP方法,蛋白质识别增加了约30%,并提供了最多的独特蛋白质识别.
- 生成了COPD唾液蛋白质和蛋白质的初步地图,确定了相关的生物通路.
结论:
- 原始诱导是呼吸系统疾病中液体活检的可行和全面来源.
- 对于唾液蛋白质和蛋白质分析,FASP方法优越.
- 这项研究为脏蛋白质组学提供了方法框架和数据集,为COPD病理学提供了洞察力.
相关概念视频
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K


